Zepp Health Corporation Q2 2026 Earnings Recap

Zepp Health’s shares rose modestly by 0.8% following Q1 2026 earnings, reflecting a generally mixed reception to solid revenue growth and margin expansion tempered by cautiousness around scale and broader market dynamics.

Key Takeaways

• Amazfit branded revenue increased 33.8% year-over-year in Q1, driven by successful launches of premium models like the ActiveMax Active 3 and T-Rex Ultra 2.
• Average selling price rose more than 20% year-over-year, supported by a higher mix of premium products, notably with nearly 50% of T-Rex family units sold in March-April coming from higher-priced models.
• Gross margin expanded despite inflationary pressures in memory and storage components, reflecting disciplined cost management and a premiumized product mix.
• The company enhanced its hybrid training ecosystem through a three-year exclusive partnership with HYROX, aimed at strengthening brand positioning in a nascent training category.
• Management emphasized strategic progress rather than a breakthrough quarter, indicating ongoing structural changes to improve pricing power and market differentiation.